Avidity Biosciences Ownership 2024 | Who Owns Avidity Biosciences Now?
Institutional Ownership
14.31%
Insider Ownership
4.89%
Retail Ownership
80.80%
Institutional Holders
65.00
Avidity Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 18.53% | 0.04% | 16,159,047 | 1,917,411 | 13.46% | 660,097,070 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 12.52% | 0.05% | 10,916,626 | 3,487,519 | 46.94% | 445,945,000 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 10.10% | 5.57% | 8,806,838 | 836,569 | 10.50% | 359,759,332 | Jun 30, 2024 |
| BLACKROCK INC. | 9.89% | 0.01% | 8,622,513 | 2,456,522 | 39.84% | 352,229,657 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 7.46% | 3.54% | 6,505,000 | 680,000 | 11.67% | 265,729,250 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.82% | 0.00% | 5,943,682 | 2,098,610 | 54.58% | 242,799,410 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 6.19% | 2.92% | 5,400,408 | 2,118,228 | 64.54% | 220,606,667 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 5.88% | 5.76% | 5,129,103 | -500,000 | -8.88% | 209,523,857 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 4.36% | 0.03% | 3,802,026 | 2,573,028 | 209.36% | 155,312,762 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 4.19% | 0.08% | 3,656,843 | 2,414,010 | 194.23% | 149,485,600 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.90% | 0.26% | 3,396,982 | 996,937 | 41.54% | 138,766,715 | Jun 30, 2024 |
| STATE STREET CORP | 3.81% | 0.01% | 3,320,019 | -141,803 | -4.10% | 135,622,776,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.59% | 0.01% | 2,256,697 | 657,023 | 41.07% | 92,204,279 | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | 2.39% | 6.53% | 2,084,841 | - | - | 85,165,755 | Jun 30, 2024 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 2.18% | 0.12% | 1,902,065 | -424,436 | -18.24% | 77,699,355 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 1.98% | 3.72% | 1,727,388 | - | - | 70,563,800 | Jun 30, 2024 |
| MORGAN STANLEY | 1.44% | 0.00% | 1,254,234 | -283,062 | -18.41% | 51,235,459 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.39% | 0.01% | 1,208,700 | 134,841 | 12.56% | 49,375,395 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 1.28% | 0.27% | 1,114,101 | 1,114,101 | 100.00% | 45,511,026 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.91% | 0.01% | 793,117 | 244,682 | 44.61% | 32,398,829 | Jun 30, 2024 |
Avidity Biosciences's largest institutional shareholder is FMR LLC, holding 18.53% of the company's total share outstanding, currently valued at $660.10M. The top 10 institutional shareholders own together 85.93% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 0.58% | 15.61% | 503,504 | -257,193 | -33.81% | 20,568,138 | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | 2.39% | 6.53% | 2,084,841 | - | - | 85,165,755 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 5.88% | 5.76% | 5,129,103 | -500,000 | -8.88% | 209,523,857 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 10.10% | 5.57% | 8,806,838 | 836,569 | 10.50% | 359,759,332 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.59% | 4.99% | 517,734 | 28,431 | 5.81% | 21,149,434 | Jun 30, 2024 |
| PROPEL BIO MANAGEMENT, LLC | 0.20% | 4.73% | 178,500 | - | - | 7,291,725 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 1.98% | 3.72% | 1,727,388 | - | - | 70,563,800 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 7.46% | 3.54% | 6,505,000 | 680,000 | 11.67% | 265,729,250 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 6.19% | 2.92% | 5,400,408 | 2,118,228 | 64.54% | 220,606,667 | Jun 30, 2024 |
| EAM GLOBAL INVESTORS LLC | 0.13% | 1.07% | 116,615 | 116,615 | 100.00% | 4,763,723 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 0.49% | 1.00% | 425,000 | 425,000 | 100.00% | 17,361,250 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 0.87% | 0.95% | 757,576 | - | - | 30,946,980 | Jun 30, 2024 |
| DARWIN GLOBAL MANAGEMENT, LTD. | 0.23% | 0.94% | 200,000 | 200,000 | 100.00% | 8,108,000 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 0.14% | 0.79% | 125,000 | 125,000 | 100.00% | 5,106,250 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 0.75% | 0.68% | 655,555 | 655,555 | 100.00% | 26,779,422 | Jun 30, 2024 |
| EAM INVESTORS, LLC | 0.10% | 0.60% | 90,635 | 90,635 | 100.00% | 3,702,440 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 0.81% | 0.57% | 706,475 | -287,625 | -28.93% | 28,859,504 | Jun 30, 2024 |
| SIMPLIFY ASSET MANAGEMENT INC. | 0.14% | 0.34% | 125,000 | - | - | 5,106,250 | Jun 30, 2024 |
| MIRADOR CAPITAL PARTNERS LP | 0.05% | 0.31% | 40,913 | -6,160 | -13.09% | 1,671,296 | Jun 30, 2024 |
| NWAM LLC | 0.03% | 0.29% | 23,916 | -3,446 | -12.59% | 976,969 | Jun 30, 2024 |
The largest Avidity Biosciences shareholder by % of total assets is ALETHEA CAPITAL MANAGEMENT, LLC. The company owns 503.50K shares of Avidity Biosciences (RNA), representing 15.61% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | 12.52% | 0.05% | 10,916,626 | 3,487,519 | 46.94% | 445,945,000 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 4.36% | 0.03% | 3,802,026 | 2,573,028 | 209.36% | 155,312,762 | Jun 30, 2024 |
| BLACKROCK INC. | 9.89% | 0.01% | 8,622,513 | 2,456,522 | 39.84% | 352,229,657 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 4.19% | 0.08% | 3,656,843 | 2,414,010 | 194.23% | 149,485,600 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 6.19% | 2.92% | 5,400,408 | 2,118,228 | 64.54% | 220,606,667 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.82% | 0.00% | 5,943,682 | 2,098,610 | 54.58% | 242,799,410 | Jun 30, 2024 |
| FMR LLC | 18.53% | 0.04% | 16,159,047 | 1,917,411 | 13.46% | 660,097,070 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 1.28% | 0.27% | 1,114,101 | 1,114,101 | 100.00% | 45,511,026 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.90% | 0.26% | 3,396,982 | 996,937 | 41.54% | 138,766,715 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 10.10% | 5.57% | 8,806,838 | 836,569 | 10.50% | 359,759,332 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.85% | 0.03% | 739,039 | 707,773 | 2263.71% | 30,189,743 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 7.46% | 3.54% | 6,505,000 | 680,000 | 11.67% | 265,729,250 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.59% | 0.01% | 2,256,697 | 657,023 | 41.07% | 92,204,279 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 0.75% | 0.68% | 655,555 | 655,555 | 100.00% | 26,779,422 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 0.49% | 1.00% | 425,000 | 425,000 | 100.00% | 17,361,250 | Jun 30, 2024 |
| LORD, ABBETT & CO. LLC | 0.48% | 0.06% | 414,340 | 414,340 | 100.00% | 16,926,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.43% | 0.03% | 377,400 | 377,400 | 100.00% | 15,416,790 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 0.43% | 0.26% | 375,924 | 375,924 | 100.00% | 15,356,495 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.44% | 0.02% | 379,802 | 368,930 | 3393.40% | 15,514,912 | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | 0.59% | 0.02% | 513,338 | 300,054 | 140.68% | 20,969,857 | Jun 30, 2024 |
As of Jun 30 2024, Avidity Biosciences's largest institutional buyer is PRICE T ROWE ASSOCIATES INC /MD/. The company purchased 3.49M stocks of RNA, valued at $445.94M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| 5AM VENTURE MANAGEMENT, LLC | - | - | - | -665,555 | -100.00% | - | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 0.01% | 0.00% | 5,000 | -601,061 | -99.17% | 204,250 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 5.88% | 5.76% | 5,129,103 | -500,000 | -8.88% | 209,523,857 | Jun 30, 2024 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 2.18% | 0.12% | 1,902,065 | -424,436 | -18.24% | 77,699,355 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.55% | 0.00% | 481,480 | -411,994 | -46.11% | 19,668,458 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.79% | 0.01% | 693,066 | -317,102 | -31.39% | 28,310,607 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 0.81% | 0.57% | 706,475 | -287,625 | -28.93% | 28,859,504 | Jun 30, 2024 |
| MORGAN STANLEY | 1.44% | 0.00% | 1,254,234 | -283,062 | -18.41% | 51,235,459 | Jun 30, 2024 |
| ALETHEA CAPITAL MANAGEMENT, LLC | 0.58% | 15.61% | 503,504 | -257,193 | -33.81% | 20,568,138 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.14% | 0.02% | 120,557 | -146,575 | -54.87% | 4,924,753 | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | 0.18% | 0.00% | 153,632 | -142,086 | -48.05% | 6,275,867 | Jun 30, 2024 |
| STATE STREET CORP | 3.81% | 0.01% | 3,320,019 | -141,803 | -4.10% | 135,622,776,000 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -135,169 | -100.00% | - | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.25% | 0.00% | 216,228 | -112,298 | -34.18% | 8,832,914 | Jun 30, 2024 |
| ABRDN PLC | 0.04% | 0.00% | 35,638 | -93,776 | -72.46% | 1,455,812 | Jun 30, 2024 |
| UBS GROUP AG | 0.12% | 0.00% | 104,383 | -91,063 | -46.59% | 4,264,046 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.04% | 0.15% | 38,855 | -84,176 | -68.42% | 1,587,227 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -75,000 | -100.00% | - | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | - | - | - | -56,997 | -100.00% | - | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 0.02% | 0.05% | 15,376 | -55,319 | -78.25% | 628,110 | Jun 30, 2024 |
As of Jun 30 2024, Avidity Biosciences's biggest institutional seller is 5AM VENTURE MANAGEMENT, LLC. The company sold -0.67M shares of RNA, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POLAR CAPITAL HOLDINGS PLC | 1.28% | 0.27% | 1,114,101 | 1,114,101 | 100.00% | 45,511,026 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 0.75% | 0.68% | 655,555 | 655,555 | 100.00% | 26,779,422 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 0.49% | 1.00% | 425,000 | 425,000 | 100.00% | 17,361,250 | Jun 30, 2024 |
| LORD, ABBETT & CO. LLC | 0.48% | 0.06% | 414,340 | 414,340 | 100.00% | 16,926,000 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 0.43% | 0.26% | 375,924 | 375,924 | 100.00% | 15,356,495 | Jun 30, 2024 |
| DARWIN GLOBAL MANAGEMENT, LTD. | 0.23% | 0.94% | 200,000 | 200,000 | 100.00% | 8,108,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.21% | 0.02% | 184,041 | 184,041 | 100.00% | 7,516,799 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 0.17% | 0.04% | 150,000 | 150,000 | 100.00% | 6,127,500 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.15% | 0.02% | 132,041 | 132,041 | 100.00% | 5,393,875 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 0.14% | 0.79% | 125,000 | 125,000 | 100.00% | 5,106,250 | Jun 30, 2024 |
| EAM GLOBAL INVESTORS LLC | 0.13% | 1.07% | 116,615 | 116,615 | 100.00% | 4,763,723 | Jun 30, 2024 |
| EAM INVESTORS, LLC | 0.10% | 0.60% | 90,635 | 90,635 | 100.00% | 3,702,440 | Jun 30, 2024 |
| CINCTIVE CAPITAL MANAGEMENT LP | 0.10% | 0.16% | 83,362 | 83,362 | 100.00% | 3,405,338 | Jun 30, 2024 |
| TREK FINANCIAL, LLC | 0.08% | 0.23% | 71,541 | 71,541 | 100.00% | 2,922,450 | Jun 30, 2024 |
| BARCLAYS PLC | 0.07% | 0.00% | 60,000 | 60,000 | 100.00% | 2,451,000 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.06% | 0.01% | 54,378 | 54,378 | 100.00% | 2,221,341 | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 0.06% | 0.26% | 50,000 | 50,000 | 100.00% | 2,042,500 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.06% | 0.00% | 48,969 | 48,969 | 100.00% | 2,000,384 | Jun 30, 2024 |
| MOSS ADAMS WEALTH ADVISORS LLC | 0.04% | 0.22% | 38,213 | 38,213 | 100.00% | 1,561,002 | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | 0.04% | 0.05% | 34,996 | 34,996 | 100.00% | 1,429,587 | Jun 30, 2024 |
| EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. | 0.03% | 0.21% | 29,992 | 29,992 | 100.00% | 1,226,973 | Jun 30, 2024 |
| ENTROPY TECHNOLOGIES, LP | 0.03% | 0.12% | 26,162 | 26,162 | 100.00% | 1,068,718 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 0.03% | 0.00% | 22,139 | 22,139 | 100.00% | 904,378 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 0.02% | 0.05% | 21,425 | 21,425 | 100.00% | 875,211 | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | 0.02% | 0.00% | 15,625 | 15,625 | 100.00% | 638,281 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.02% | 0.11% | 15,363 | 15,363 | 100.00% | 627,579 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.01% | 0.00% | 12,042 | 12,042 | 100.00% | 491,916 | Jun 30, 2024 |
| NEWEDGE ADVISORS, LLC | 0.01% | 0.00% | 10,967 | 10,967 | 100.00% | 448,005 | Jun 30, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | 0.01% | 0.00% | 10,200 | 10,200 | 100.00% | 416,670 | Jun 30, 2024 |
| STRS OHIO | 0.01% | 0.00% | 10,000 | 10,000 | 100.00% | 408,500,000 | Jun 30, 2024 |
| 9258 WEALTH MANAGEMENT, LLC | 0.01% | 0.06% | 9,657 | 9,657 | 100.00% | 394,488 | Jun 30, 2024 |
| HARVEST INVESTMENT SERVICES, LLC | 0.01% | 0.15% | 9,068 | 9,068 | 100.00% | 370,428 | Jun 30, 2024 |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 0.01% | 0.00% | 7,806 | 7,806 | 100.00% | 319,000 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.01% | 0.00% | 7,405 | 7,405 | 100.00% | 302,494 | Jun 30, 2024 |
| MARINER, LLC | 0.01% | 0.00% | 7,242 | 7,242 | 100.00% | 295,836 | Jun 30, 2024 |
| MIRABELLA FINANCIAL SERVICES LLP | 0.01% | 0.02% | 7,022 | 7,022 | 100.00% | 286,849 | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | 0.01% | 0.00% | 7,000 | 7,000 | 100.00% | 285,950 | Jun 30, 2024 |
| DORSEY & WHITNEY TRUST CO LLC | 0.01% | 0.02% | 6,990 | 6,990 | 100.00% | 285,542 | Jun 30, 2024 |
| QUANTINNO CAPITAL MANAGEMENT LP | 0.01% | 0.00% | 6,588 | 6,588 | 100.00% | 269,120 | Jun 30, 2024 |
| XPONANCE, INC. | 0.01% | 0.00% | 6,421 | 6,421 | 100.00% | 262,298 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.01% | 0.00% | 6,369 | 6,369 | 100.00% | 260,173 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.01% | 0.00% | 5,513 | 5,513 | 100.00% | 225,206 | Jun 30, 2024 |
| ARETE WEALTH ADVISORS, LLC | 0.01% | 0.02% | 5,100 | 5,100 | 100.00% | 208,000 | Jun 30, 2024 |
| KBC GROUP NV | 0.00% | 0.00% | 2,248 | 2,248 | 100.00% | 92,000 | Jun 30, 2024 |
| CREATIVE CAPITAL MANAGEMENT INVESTMENTS LLC | 0.00% | 0.03% | 1,603 | 1,603 | 100.00% | 65,483 | Jun 30, 2024 |
| GLOBAL RETIREMENT PARTNERS, LLC | 0.00% | 0.00% | 600 | 600 | 100.00% | 24,510 | Jun 30, 2024 |
| TWIN TREE MANAGEMENT, LP | 0.00% | - | 206 | 206 | 100.00% | 8,415 | Jun 30, 2024 |
| COMERICA BANK | 0.00% | - | 183 | 183 | 100.00% | 7,476 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 90 | 90 | 100.00% | 3,648 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 88 | 88 | 100.00% | 3,595 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | 0.00% | 49 | 49 | 100.00% | 2,002 | Jun 30, 2024 |
| CVA FAMILY OFFICE, LLC | - | 0.00% | 20 | 20 | 100.00% | 817 | Jun 30, 2024 |
| PLANNING CAPITAL MANAGEMENT CORP | - | 0.00% | 12 | 12 | 100.00% | 491 | Jun 30, 2024 |
Avidity Biosciences's largest new institutional shareholder by number of shares is POLAR CAPITAL HOLDINGS PLC, purchased 1.11M shares, valued at $45.51M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| 5AM VENTURE MANAGEMENT, LLC | - | - | - | -665,555 | -100.00% | - | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -135,169 | -100.00% | - | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -75,000 | -100.00% | - | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | - | - | - | -56,997 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -51,055 | -100.00% | - | Jun 30, 2024 |
| HARBOR CAPITAL ADVISORS, INC. | - | - | - | -40,068 | -100.00% | - | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | - | - | - | -37,031 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -36,455 | -100.00% | - | Jun 30, 2024 |
| CONCURRENT INVESTMENT ADVISORS, LLC | - | - | - | -26,005 | -100.00% | - | Jun 30, 2024 |
| CORTON CAPITAL INC. | - | - | - | -24,954 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -24,654 | -100.00% | - | Jun 30, 2024 |
| BRIDGEFRONT CAPITAL, LLC | - | - | - | -11,485 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -10,055 | -100.00% | - | Jun 30, 2024 |
| TEXAS YALE CAPITAL CORP. | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | - | - | - | -9,186 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -3,869 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -15 | -100.00% | - | Jun 30, 2024 |
| HOLLENCREST CAPITAL MANAGEMENT | - | - | - | -10 | -100.00% | - | Jun 30, 2024 |
Avidity Biosciences's largest sold out institutional shareholder by shares sold is 5AM VENTURE MANAGEMENT, LLC, sold -0.67M shares, valued at -, as of undefined.
Avidity Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Alger ETF Trust | 1.43% | 10,171 | - | - | Dec 31, 2023 |
| T. Rowe Price New Horizons Fund, Inc. | 0.72% | 3,620,888 | 80,334 | 2.27% | Mar 31, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.68% | 168,164 | - | - | Dec 31, 2023 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.38% | 1,282,164 | -64,927 | -4.82% | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.27% | 129,414 | - | - | Mar 31, 2024 |
| ALGER FUNDS II | 0.20% | 45,282 | - | - | Jan 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.19% | 594,492 | 173,718 | 41.29% | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.16% | 595,531 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.13% | 3,624,789 | 20,296 | 0.56% | Feb 29, 2024 |
| ALGER INSTITUTIONAL FUNDS | 0.11% | 29,546 | - | - | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.09% | 794,880 | -205,120 | -20.51% | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.09% | 45,515 | - | - | Mar 31, 2024 |
| ALGER PORTFOLIOS | 0.08% | 31,395 | - | - | Dec 31, 2023 |
| CORNERCAP GROUP OF FUNDS /VA/ | 0.08% | 5,825 | - | - | Sep 30, 2022 |
| BlackRock Health Sciences Trust II | 0.08% | 202,106 | - | - | Mar 31, 2024 |
| ALGER FUNDS | 0.07% | 70,040 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.07% | 190,000 | 40,000 | 26.67% | Mar 31, 2024 |
| Humankind Benefit Corp | 0.06% | 1,407 | 336 | 31.37% | Dec 31, 2023 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.05% | 26,540 | - | - | Mar 31, 2024 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.05% | 142,524 | - | - | Mar 31, 2024 |
| Vericimetry Funds | 0.04% | 3,630 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.04% | 58,184 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.03% | 2,168,441 | 286,591 | 15.23% | Feb 29, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.03% | 249,880 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.03% | 317,871 | - | - | Mar 31, 2024 |
| ACAP Strategic Fund | 0.03% | 382,045 | - | - | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.02% | 4,099 | - | - | Mar 28, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 130,924 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 10,954 | - | - | Mar 31, 2024 |
| IndexIQ ETF Trust | 0.01% | 31,029 | - | - | Jan 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.01% | 109,386 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.01% | 29,636 | 12,303 | 70.98% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,867 | 1,560 | 119.36% | Mar 31, 2024 |
| Collaborative Investment Series Trust | 0.01% | 1,359 | - | - | Mar 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.01% | 36,300 | - | - | Mar 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.01% | 400,000 | 40,000 | 11.11% | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.01% | 146,918 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 3,072,916 | -1,294,969 | -29.65% | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 10,219 | 2,106 | 25.96% | Jan 31, 2024 |
| Nushares ETF Trust | 0.01% | 49,664 | 12,566 | 33.87% | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 202,178 | 8,014 | 4.13% | Jan 31, 2024 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.00% | 3,224 | 165 | 5.39% | Sep 30, 2023 |
| ALPS ETF Trust | 0.00% | 54,669 | 2,330 | 4.45% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 90,000 | -10,000 | -10.00% | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 33,009 | - | - | Mar 28, 2024 |
| MUTUAL OF AMERICA INVESTMENT CORP | 0.00% | 137,691 | -2,820 | -2.01% | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 9,170 | 8,090 | 749.07% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 634,800 | 35,099 | 5.85% | Feb 29, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 259,567 | - | - | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 62,812 | 487 | 0.78% | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 7,024 | - | - | Mar 31, 2024 |
| OLD WESTBURY FUNDS INC | 0.00% | 314,734 | -10,218 | -3.14% | Jan 31, 2024 |
| Simplify Exchange Traded Funds | 0.00% | 125,000 | - | - | Mar 28, 2024 |
| Harbor ETF Trust | 0.00% | 9,384 | -772 | -7.60% | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 259,517 | -59,194 | -18.57% | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 30,863 | -495 | -1.58% | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 42,420 | -10,385 | -19.67% | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 535,168 | 104,399 | 24.24% | Jan 31, 2024 |
| T. Rowe Price Exchange-Traded Funds, Inc. | 0.00% | 7,384 | 7,384 | - | Mar 31, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 46,538 | 39,529 | 563.97% | Mar 31, 2024 |
| BlackRock ETF Trust | 0.00% | 899 | - | - | Jan 31, 2024 |
| HARBOR FUNDS | 0.00% | 22,056 | -1,643 | -6.93% | Jan 31, 2024 |
| ARTISAN PARTNERS FUNDS INC | 0.00% | 1,457,894 | 121,379 | 9.08% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 79,201 | -51,529 | -39.42% | Jan 31, 2024 |
| ProFunds | 0.00% | 10,778 | -843 | -7.25% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 201,449 | 8,595 | 4.46% | Feb 29, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND VI | 0.00% | 4,410 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 24,521 | -4,762 | -16.26% | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 9,136 | -1,039 | -10.21% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 3,539 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 29,024 | -98,232 | -77.19% | Jan 31, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 9,058 | - | - | Feb 29, 2024 |
| World Funds Trust | 0.00% | 7,500 | - | - | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 353,564 | 28,403 | 8.74% | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 578,442 | -155,386 | -21.17% | Jan 31, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 90,154 | - | - | Jan 31, 2024 |
| NEW COVENANT FUNDS | 0.00% | 2,388 | - | - | Dec 31, 2023 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 1,631 | - | - | Feb 29, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 590,100 | -89,300 | -13.14% | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 507,161 | 242,580 | 91.68% | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 26,100 | 1,800 | 7.41% | Mar 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 42,531 | -59,050 | -58.13% | Mar 31, 2024 |
| PRUDENTIAL SERIES FUND | 0.00% | 29,525 | - | - | Mar 28, 2024 |
| VALIC Co I | 0.00% | 103,465 | 7,154 | 7.43% | Feb 29, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 1,600 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 3,932 | 428 | 12.21% | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 44,693 | -332 | -0.74% | Mar 28, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 4,762 | - | - | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 1,108 | - | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 5,306 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 138 | - | - | Apr 30, 2021 |
| JPMORGAN TRUST II | 0.00% | 223,366 | - | - | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 24,707 | 24,707 | - | Feb 29, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 886 | - | - | Mar 28, 2024 |
| iSHARES TRUST | 0.00% | 3,292,574 | -175,797 | -5.07% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 235,394 | -5,166 | -2.15% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 324,425 | 45,465 | 16.30% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 645 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 18,928 | -38 | -0.20% | Jan 31, 2024 |
| Trust for Advised Portfolios | 0.00% | 2,802 | - | - | Dec 31, 2023 |
Avidity Biosciences's largest mutual fund holder by % of total assets is "Alger ETF Trust", owning 10.17K shares, compromising 1.43% of its total assets.
Avidity Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 65 | -59.63% |
| 31 Mar, 24 | 161 | 10.27% |
| 31 Dec, 23 | 146 | 2.10% |
| 30 Sep, 23 | 143 | - |
| 30 Jun, 23 | 143 | 2.14% |
| 31 Mar, 23 | 140 | -7.89% |
| 31 Dec, 22 | 152 | 23.58% |
| 30 Sep, 22 | 123 | 10.81% |
| 30 Jun, 22 | 111 | 8.82% |
| 31 Mar, 22 | 102 | -2.86% |
| 31 Dec, 21 | 105 | -4.55% |
| 30 Sep, 21 | 110 | 18.28% |
| 30 Jun, 21 | 93 | -7.00% |
| 31 Mar, 21 | 100 | 21.95% |
| 31 Dec, 20 | 82 | 24.24% |
| 30 Sep, 20 | 66 | 26.92% |
| 30 Jun, 20 | 52 | - |
As of 30 Jun 24, 65 institutions are holding Avidity Biosciences's shares, representing a decrease of -59.63% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 12,482,857 | -86.02% |
| 31 Mar, 24 | 89,302,004 | 17.64% |
| 31 Dec, 23 | 75,911,614 | -7.12% |
| 30 Sep, 23 | 81,728,178 | -0.85% |
| 30 Jun, 23 | 82,428,961 | 8.59% |
| 31 Mar, 23 | 75,905,578 | 6.01% |
| 31 Dec, 22 | 71,605,539 | 34.08% |
| 30 Sep, 22 | 53,403,120 | 2.44% |
| 30 Jun, 22 | 52,132,961 | 2.12% |
| 31 Mar, 22 | 51,050,587 | 12.40% |
| 31 Dec, 21 | 45,420,355 | 2.30% |
| 30 Sep, 21 | 44,397,347 | 28.56% |
| 30 Jun, 21 | 34,533,739 | 1.50% |
| 31 Mar, 21 | 34,022,811 | 9.88% |
| 31 Dec, 20 | 30,963,834 | 14.66% |
| 30 Sep, 20 | 27,005,361 | 6.08% |
| 30 Jun, 20 | 25,458,553 | - |
Avidity Biosciences (RNA) has 12.48M shares outstanding as of 30 Jun 24, down -86.02% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 14.31% | 0.14% |
| 31 Mar, 24 | 102.40% | 0.95% |
| 31 Dec, 23 | 103.97% | 0.85% |
| 30 Sep, 23 | 110.30% | 0.83% |
| 30 Jun, 23 | 115.46% | 0.99% |
| 31 Mar, 23 | 107.77% | 0.69% |
| 31 Dec, 22 | 124.97% | 1.23% |
| 30 Sep, 22 | 100.63% | 0.92% |
| 30 Jun, 22 | 104.42% | 0.93% |
| 31 Mar, 22 | 105.87% | 0.88% |
| 31 Dec, 21 | 109.64% | 0.95% |
| 30 Sep, 21 | 107.17% | 0.42% |
| 30 Jun, 21 | 159.41% | 0.65% |
| 31 Mar, 21 | 157.05% | 0.77% |
| 31 Dec, 20 | 142.93% | 0.92% |
| 30 Sep, 20 | 124.66% | 1.84% |
| 30 Jun, 20 | 82.25% | - |
As of 30 Jun 24, Avidity Biosciences is held by 14.31% institutional shareholders, representing a 0.14% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 44 | -51.11% |
| 31 Mar, 24 | 90 | 15.38% |
| 31 Dec, 23 | 78 | -2.50% |
| 30 Sep, 23 | 80 | -9.09% |
| 30 Jun, 23 | 88 | -3.30% |
| 31 Mar, 23 | 91 | -22.88% |
| 31 Dec, 22 | 118 | 78.79% |
| 30 Sep, 22 | 66 | 8.20% |
| 30 Jun, 22 | 61 | 27.08% |
| 31 Mar, 22 | 48 | -7.69% |
| 31 Dec, 21 | 52 | -24.64% |
| 30 Sep, 21 | 69 | 86.49% |
| 30 Jun, 21 | 37 | -45.59% |
| 31 Mar, 21 | 68 | 30.77% |
| 31 Dec, 20 | 52 | 23.81% |
| 30 Sep, 20 | 42 | -19.23% |
| 30 Jun, 20 | 52 | - |
44 institutional shareholders have increased their position in RNA stock as of 30 Jun 24 compared to 90 in the previous quarter (a -51.11% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 17 | -65.31% |
| 31 Mar, 24 | 49 | 6.52% |
| 31 Dec, 23 | 46 | 17.95% |
| 30 Sep, 23 | 39 | 18.18% |
| 30 Jun, 23 | 33 | 26.92% |
| 31 Mar, 23 | 26 | 30.00% |
| 31 Dec, 22 | 20 | -35.48% |
| 30 Sep, 22 | 31 | 72.22% |
| 30 Jun, 22 | 18 | -30.77% |
| 31 Mar, 22 | 26 | - |
| 31 Dec, 21 | 26 | 30.00% |
| 30 Sep, 21 | 20 | -31.03% |
| 30 Jun, 21 | 29 | 141.67% |
| 31 Mar, 21 | 12 | -20.00% |
| 31 Dec, 20 | 15 | - |
| 30 Sep, 20 | 15 | - |
| 30 Jun, 20 | - | - |
17 institutional shareholders have reduced their position in RNA stock as of 30 Jun 24 compared to 49 in the previous quarter (a -65.31% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 65 | -59.63% | 12,482,857 | -86.02% | 14.31% | 0.14% | 44 | -51.11% | 17 | -65.31% |
| 31 Mar, 24 | 161 | 10.27% | 89,302,004 | 17.64% | 102.40% | 0.95% | 90 | 15.38% | 49 | 6.52% |
| 31 Dec, 23 | 146 | 2.10% | 75,911,614 | -7.12% | 103.97% | 0.85% | 78 | -2.50% | 46 | 17.95% |
| 30 Sep, 23 | 143 | - | 81,728,178 | -0.85% | 110.30% | 0.83% | 80 | -9.09% | 39 | 18.18% |
| 30 Jun, 23 | 143 | 2.14% | 82,428,961 | 8.59% | 115.46% | 0.99% | 88 | -3.30% | 33 | 26.92% |
| 31 Mar, 23 | 140 | -7.89% | 75,905,578 | 6.01% | 107.77% | 0.69% | 91 | -22.88% | 26 | 30.00% |
| 31 Dec, 22 | 152 | 23.58% | 71,605,539 | 34.08% | 124.97% | 1.23% | 118 | 78.79% | 20 | -35.48% |
| 30 Sep, 22 | 123 | 10.81% | 53,403,120 | 2.44% | 100.63% | 0.92% | 66 | 8.20% | 31 | 72.22% |
| 30 Jun, 22 | 111 | 8.82% | 52,132,961 | 2.12% | 104.42% | 0.93% | 61 | 27.08% | 18 | -30.77% |
| 31 Mar, 22 | 102 | -2.86% | 51,050,587 | 12.40% | 105.87% | 0.88% | 48 | -7.69% | 26 | - |
| 31 Dec, 21 | 105 | -4.55% | 45,420,355 | 2.30% | 109.64% | 0.95% | 52 | -24.64% | 26 | 30.00% |
| 30 Sep, 21 | 110 | 18.28% | 44,397,347 | 28.56% | 107.17% | 0.42% | 69 | 86.49% | 20 | -31.03% |
| 30 Jun, 21 | 93 | -7.00% | 34,533,739 | 1.50% | 159.41% | 0.65% | 37 | -45.59% | 29 | 141.67% |
| 31 Mar, 21 | 100 | 21.95% | 34,022,811 | 9.88% | 157.05% | 0.77% | 68 | 30.77% | 12 | -20.00% |
| 31 Dec, 20 | 82 | 24.24% | 30,963,834 | 14.66% | 142.93% | 0.92% | 52 | 23.81% | 15 | - |
| 30 Sep, 20 | 66 | 26.92% | 27,005,361 | 6.08% | 124.66% | 1.84% | 42 | -19.23% | 15 | - |
| 30 Jun, 20 | 52 | - | 25,458,553 | - | 82.25% | - | 52 | - | - | - |
Avidity Biosciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Avidity Biosciences's stock was made by Boyce Sarah on Aug 07 2024, selling 28,000 shares at $1.24 per share (valued at $34.72K).
Avidity Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 5 | 6 | 83.33% |
| Q2 2024 | 27 | 29 | 93.10% |
| Q1 2024 | 14 | 18 | 77.78% |
| Q4 2023 | 1 | 2 | 50.00% |
| Q3 2023 | 4 | - | - |
| Q2 2023 | 7 | - | - |
| Q1 2023 | 16 | 13 | 123.08% |
| Q4 2022 | 1 | 2 | 50.00% |
| Q3 2022 | 5 | 11 | 45.45% |
| Q2 2022 | 9 | - | - |
| Q1 2022 | 5 | - | - |
| Q4 2021 | 2 | 3 | 66.67% |
| Q3 2021 | 2 | - | - |
| Q2 2021 | 9 | 12 | 75.00% |
| Q1 2021 | 11 | 5 | 220.00% |
| Q4 2020 | 1 | 1 | 100.00% |
| Q3 2020 | 1 | - | - |
| Q2 2020 | 9 | 25 | 36.00% |
| Q3 2003 | - | 5 | - |
| Q2 2003 | 2 | - | - |
5 total buy trades, and 6 total sell trades (buy/sell ratio of 0.83%) were made by Avidity Biosciences's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 3 | - |
| Q2 2024 | - | 18 | - |
| Q1 2024 | - | 12 | - |
| Q4 2023 | - | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | 7 | - |
| Q4 2022 | - | 1 | - |
| Q3 2022 | - | 5 | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | 1 | - |
| Q3 2021 | 1 | - | - |
| Q2 2021 | - | 6 | - |
| Q1 2021 | - | 1 | - |
| Q4 2020 | - | - | - |
| Q3 2020 | - | - | - |
| Q2 2020 | 2 | - | - |
| Q3 2003 | - | - | - |
| Q2 2003 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 3 open market sell trades of Avidity Biosciences's stocks.
Avidity Biosciences Peer Ownership
| Ticker | Company |
|---|---|
| PLRX | Pliant Therapeutics, Inc. |
| AKRO | Akero Therapeutics, Inc. |
| ARVN | Arvinas, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| MLYS | Mineralys Therapeutics, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| CERE | Cerevel Therapeutics Holdings, Inc. |
| BDTX | Black Diamond Therapeutics, Inc. |
| RLAY | Relay Therapeutics, Inc. |
| BCEL | Atreca, Inc. |
| IGMS | IGM Biosciences, Inc. |
| PASG | Passage Bio, Inc. |
| SWTX | SpringWorks Therapeutics, Inc. |
| PTGX | Protagonist Therapeutics, Inc. |
RNA Ownership FAQ
Who Owns Avidity Biosciences?
Avidity Biosciences is owned by institutional shareholders (14.31%), insiders (4.89%), and public (80.80%). The largest institutional shareholder of Avidity Biosciences is FMR LLC (18.53% of total shares) and the top mutual fund owner is Alger ETF Trust (1.43% of total shares).
Who are the major institutional shareholders of Avidity Biosciences?
Avidity Biosciences's major institutional shareholders are FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, RTW INVESTMENTS, LP, BLACKROCK INC., and AVORO CAPITAL ADVISORS LLC. The top five shareholders own together 58.49% of the company's share outstanding.
How many Avidity Biosciences shareholders are there?
As of Jun 2024, there are 65 institutional shareholders of Avidity Biosciences.
What percentage of Avidity Biosciences is owned by FMR LLC?
FMR LLC owns 16.16M shares of Avidity Biosciences, representing 18.53% of the company's total shares outstanding, valued at $660.1M (as of Jun 2024).
What percentage of Avidity Biosciences is owned by PRICE T ROWE ASSOCIATES INC /MD/?
As of Jun 2024, PRICE T ROWE ASSOCIATES INC /MD/ holds 10.92M shares of Avidity Biosciences (RNA), compromising 12.52% of the company, valued at $445.94M.
What percentage of Avidity Biosciences is owned by RTW INVESTMENTS, LP?
RTW INVESTMENTS, LP is the third largest holder of Avidity Biosciences. The company owns 8.81M of the company's shares outstanding (worth $359.76M).